FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileTema Cardiovascular and Metabolic ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
HRTS
Tema Cardiovascular and Metabolic ETF ETF AnalysisComprehensive ETF analysis for Tema Cardiovascular and Metabolic ETF (HRTS) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisHRTS
HRTS
Tema Cardiovascular and Metabolic ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
HRTS
  1. Home
  2. Screener
  3. Tema Cardiovascular and Metabolic ETFHRTSETF
Tema Cardiovascular and Metabolic ETF Logo

Tema Cardiovascular and Metabolic ETF

ETF
🇺🇸HRTS•NASDAQ•Equity

Your view on HRTS

Tema Cardiovascular and Metabolic ETF Logo

Tema Cardiovascular and Metabolic ETF

ETFTema
🇺🇸HRTS•NASDAQ•Equity
AUM (USD)$57.71M
Expense Ratio0.99%
Yield (TTM)1.25%
Holdings46

Sentiment

—

AUM (USD)

$57.71M

Expense Ratio

0.99%

Yield (TTM)

1.25%

Holdings

46

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Tema Cardiovascular and Metabolic ETF (HRTS) is an Equity fund from Tema, listed since 2023, with $57.7M in assets under management, a 0.99% expense ratio and a NAV of $39.00 USD.

Overview for Tema Cardiovascular and Metabolic ETF

Fund Type
ETF
Fund Issuer
Tema
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
November 20, 2023
Domicile
US
Website
temaetfs.com/hrts
Fund Type
ETF
Fund Issuer
Tema
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
November 20, 2023
Domicile
US
Website
temaetfs.com/hrts
Fund Type
ETF
Fund Issuer
Tema
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
November 20, 2023
Domicile
US
Website
temaetfs.com/hrts

About this fund

The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.99%

Yield (TTM)

1.25%

AUM

$57.71M

Fund Details

NAV$39.00 USD
Holdings46
Average Volume3.4K
Inception DateNovember 20, 2023
Asset ClassEquity
Fund IssuerTema
DomicileUS
ISINUS87975E8839
CUSIP87975E883
NAV CurrencyUSD

Expense Ratio

0.99%

Dividend Yield (TTM)

1.25%

Assets Under Management

$57.71M

NAV

$39.00 USD

Holdings

46

Average Volume

3.4K

Inception Date

November 20, 2023

Asset Class

Equity

Fund Issuer

Tema

Domicile

US

ISIN

US87975E8839

CUSIP

87975E883

NAV Currency

USD

Expense Ratio

0.99%

Dividend Yield (TTM)

1.25%

Assets Under Management

$57.71M

NAV

$39.00 USD

Holdings

46

Average Volume

3.4K

Inception Date

November 20, 2023

Asset Class

Equity

Fund Issuer

Tema

Domicile

US

ISIN

US87975E8839

CUSIP

87975E883

NAV Currency

USD

Distributions · last 12 months

Annual · 1 payment

Ex-datePaidAmount
Dec 10, 2025Dec 11, 2025$0.4729
Total, 12 months$0.47 a share

Dividend yield (TTM) 1.25% = $0.47 paid per share in the 12 months to Nov 20, 2026 ÷ the $37.75 price. Past distributions; future payments can differ.

Data last updated: Nov 14, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

46 positions
1LLYELI LILLY & CO
12.54%
2TMOTHERMO FISHER SCIENTIFIC INC
5.48%
3RHHBYROCHE HOLDING AG
4.42%
4MRKMERCK & CO INC
3.97%
5BBIOBRIDGEBIO PHARMA INC
3.87%
6KODKODIAK SCIENCES INC
3.85%
7GILDGILEAD SCIENCES INC
3.52%
8DHRDANAHER CORP
3.19%
9RVMDREVOLUTION MEDICINES INC
3.09%
10NOVO-B.CONOVO NORDISK A/S
2.97%
11ABTABBOTT LABORATORIES
2.93%
12AZN.LASTRAZENECA PLC
2.90%
13JNJJOHNSON & JOHNSON
2.84%
14NOVN.SWNOVARTIS AG
2.79%
15VRTXVERTEX PHARMACEUTICALS INC
2.64%

Concentration

Total Holdings46
Top 10 Weight46.91%
Top HoldingLLY
Top Weight12.54%
1LLYELI LILLY & CO
12.54%
2TMOTHERMO FISHER SCIENTIFIC INC
5.48%
3RHHBYROCHE HOLDING AG
4.42%
4MRKMERCK & CO INC
3.97%
5BBIOBRIDGEBIO PHARMA INC
3.87%
6KODKODIAK SCIENCES INC
3.85%
7GILDGILEAD SCIENCES INC
3.52%
8DHRDANAHER CORP
3.19%
9RVMDREVOLUTION MEDICINES INC
3.09%
10NOVO-B.CONOVO NORDISK A/S
2.97%
11ABTABBOTT LABORATORIES
2.93%
12AZN.LASTRAZENECA PLC
2.90%
13JNJJOHNSON & JOHNSON
2.84%
14NOVN.SWNOVARTIS AG
2.79%
15VRTXVERTEX PHARMACEUTICALS INC
2.64%

Total Holdings

46

Top 10 Weight

46.91%

Top Holding

LLY

Top Weight

12.54%

1LLYELI LILLY & CO
12.54%$6.90M
2TMOTHERMO FISHER SCIENTIFIC INC
5.48%$3.02M
3RHHBYROCHE HOLDING AG
4.42%$2.43M
4MRKMERCK & CO INC
3.97%$2.19M
5BBIOBRIDGEBIO PHARMA INC
3.87%$2.13M
6KODKODIAK SCIENCES INC
3.85%$2.12M
7GILDGILEAD SCIENCES INC
3.52%$1.94M
8DHRDANAHER CORP
3.19%$1.75M
9RVMDREVOLUTION MEDICINES INC
3.09%$1.70M
10NOVO-B.CONOVO NORDISK A/S
2.97%$1.63M
11ABTABBOTT LABORATORIES
2.93%$1.61M
12AZN.LASTRAZENECA PLC
2.90%$1.60M
13JNJJOHNSON & JOHNSON
2.84%$1.56M
14NOVN.SWNOVARTIS AG
2.79%$1.53M
15VRTXVERTEX PHARMACEUTICALS INC
2.64%$1.45M

Total Holdings

46

Top 10 Weight

46.91%

Top Holding

LLY

Top Weight

12.54%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on16 funds
FundAsset classExpense ratioAssetsHoldings
HRTSTema Cardiovascular and Metabolic ETFThis fundEquity0.99%$58M46

Comparable funds

  • AHLTAmerican Beacon Select Funds - Ahl Liquid Trend ETFEquity0.96%$171M32
  • FMETFIDELITY METAVERSE ETFEquity0.39%$40M61
  • FTWOStrive Natural Resources and Security ETFEquity0.49%$74M52
  • ITDDiShares LifePath Target Date 2040 ETFMulti-Asset0.11%$125M13
  • KDEFPLUS Korea Defense Industry Index ETFEquity0.65%$80M20
  • NDIAGlobal X - India Active ETFEquity0.75%$55M30
  • PUIInvesco Dorsey Wright Utilities Momentum ETFEquity0.82%$49M38
  • PYZInvesco Dorsey Wright Basic Materials Momentum ETFEquity0.79%$63M41

More Tema ETFs

  • CANCTema Oncology ETFEquity0.99%$215M56
  • DISKTEMA MEMORY ETFEquity0.75%$43M18
  • DSPYTema S&P 500 Historical Weight ETF StrategyEquity0.18%$987M505
  • NASATema Space Innovators ETFEquity0.75%$873M37
  • PRVTTema Listed Private Managers ETFEquity0.99%$234,6561
  • TOLLTema Durable Quality ETFEquity0.55%$46M39
  • WELDTema U.S. Manufacturing & Reshoring ETFEquity0.75%$194M22
  • ARMYTema International Defense Innovation ETFEquity0.75%$12M37
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News